For the Guidant acquisition to be a success, locking in Tobin is an important component, given his skills as an operator. |
J&J raised its 'full and fair value' offer to a fuller and apparently fairer $68.06 a share, upping the cash portion by $4 to $37.25. |
The more the battle for Guidant becomes a bidding war ... the higher the probability that the true economics of the deal accrue to Guidant shareholders and not to those of the 'winner' bidder. |
The timing and scope of the FDA warning letter was as much about the politics at the FDA and mandate for systemic change than it was about Boston Scientific. |
We would not read too much into the new 'definitive' agreement between J&J and Guidant, as such agreement can prove as ephemeral as a marriage certificate in Las Vegas. |